A weekly injection slowed kidney decline in IgA nephropathy over two years
In the final analysis of the ORIGIN 3 trial, published Oct. 22, 2026, in the New England Journal of Medicine, atacicept nearly stopped the yearly loss of kidney function in IgA nephropathy,…